Delving into the Latest Updates on Neosil, Inc. with Synapse

Overview

A Phase 2 Two-Center, Randomized, Double-blind, Placebo-controlled, Paired Treatment Site Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Reduction of Wound Bioburden among Adults Treated with Curettage & Electrodessication for Superficial Basal Cell Carcinomas of the Trunk and Extremities

Start Date10 Sep 2007

Sponsor / Collaborator

Neosil, Inc.

ACTRN12607000447459 / SuspendedPhase 1/2

A Phase 1/2 Single Center, Randomized, Double-blind, Placebo-controlled, Left-Right Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Older Adolescents and Adults with at least Moderate Atopic Dermatitis

Start Date10 Sep 2007

Sponsor / Collaborator

Neosil, Inc.

ACTRN12607000267459 / CompletedPhase 1/2

A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in the Reduction or Eradication of Staphylococcus aureus Nasal Carriage among Adults

Start Date08 Jun 2007

Sponsor / Collaborator

Neosil, Inc.

100 Clinical Results associated with Neosil, Inc.

Login to view more data

0 Patents (Medical) associated with Neosil, Inc.

Login to view more data

100 Deals associated with Neosil, Inc.

Login to view more data

100 Translational Medicine associated with Neosil, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data